WhatsApp
backNews Article

Procter & Gamble Hygiene and Health Care Limited Reports ₹43,165 Lakh Profit Before Tax for H1 FY2027 Ending September 30, 2026

Company posts ₹26,202 lakh profit before tax in Q2 with revenue from operations at ₹1,14,558 lakh, as per unaudited financial results

Procter & Gamble Hygiene and Health Care Limited announced its unaudited financial results for the quarter and half year ended September 30, 2026, reporting a profit before tax of ₹26,202 lakh for Q2 and ₹43,165 lakh for H1 FY2027. Total revenue from operations reached ₹1,14,558 lakh in Q2 and ₹2,03,654 lakh in H1, with detailed cost and cash flow statements included.

7 days ago|PGHH+4.34%
Procter & Gamble Hygiene and Health Care LimitedPGHHFinancial Results

Procter & Gamble Hygiene and Health Care Limited

Financial Results

Procter & Gamble Hygiene and Health Care Limited announced its unaudited financial results for the quarter and half year ended September 30, 2026, showing a profit before tax of ₹26,202 lakh for Q2 and ₹43,165 lakh for H1 FY2027.

The company reported revenue from operations of ₹1,14,558 lakh for the quarter and ₹2,03,654 lakh for the half year ended September 30, 2026.

Total income including other income was ₹1,16,209 lakh for Q2 and ₹2,06,298 lakh for H1.

Expenses for Q2 stood at ₹90,007 lakh and ₹1,63,133 lakh for H1, covering raw material costs, stock purchases, and employee benefits among others.

The profit after tax was ₹19,584 lakh for the quarter and ₹32,211 lakh for the half year.

Earnings per share for the quarter were ₹60.33 basic and diluted, and ₹99.23 basic with ₹123.82 diluted for the half year, based on a ₹10 face value per share.

Highlights

  • Profit before tax of ₹26,202 lakh for Q2 and ₹43,165 lakh for H1 FY2027.
  • Revenue from operations of ₹1,14,558 lakh in Q2 and ₹2,03,654 lakh in H1.
  • Profit after tax recorded at ₹19,584 lakh for Q2 and ₹32,211 lakh for H1.
  • Earnings per share of ₹60.33 basic and ₹60.33 diluted for Q2.
  • Unaudited financial results subject to limited review by statutory auditors.
  • Segment reporting combines health care and hygiene products under single primary segment per Ind AS 108.

Key Data Snapshot

Profit before tax in Q2 FY2027₹26,202 lakh
Profit before tax in H1 FY2027₹43,165 lakh
Revenue from operations in Q2 FY2027₹1,14,558 lakh
Revenue from operations in H1 FY2027₹2,03,654 lakh
Profit after tax in Q2 FY2027₹19,584 lakh
Profit after tax in H1 FY2027₹32,211 lakh
Basic earnings per share for Q2 FY2027₹60.33
Basic earnings per share for H1 FY2027₹99.23
Diluted earnings per share for Q2 FY2027₹60.33
Diluted earnings per share for H1 FY2027₹123.82
Reporting period end dateSeptember 30, 2026

What happened

  • Procter & Gamble Hygiene and Health Care Limited approved unaudited financial results for quarter and half year ended September 30, 2026.
  • Reported total revenue from operations of ₹1,14,558 lakh in Q2 and ₹2,03,654 lakh in H1 FY2027.
  • Recorded a profit before tax of ₹26,202 lakh in Q2 and ₹43,165 lakh in H1 FY2027.
  • Profit after tax amounts to ₹19,584 lakh for Q2 and ₹32,211 lakh for the half year.

Key details

  • Earnings per share for Q2 were ₹60.33 basic and ₹60.33 diluted for a face value of ₹10 per equity share.
  • For the half year, basic earnings per share stood at ₹99.23 and diluted at ₹123.82.
  • Expenses include cost of raw materials, stock purchases, employee benefits, finance costs, depreciation, advertising, and other expenses.
  • Financial results have been reviewed by Audit Committee and approved by Board of Directors on November 12, 2026.
  • The results have undergone limited review by statutory auditors as per SEBI regulations.

Financial performance

  • Total income including other income was ₹1,16,209 lakh in Q2 and ₹2,06,298 lakh in H1 FY2027.
  • Total expenses were ₹90,007 lakh for Q2 and ₹1,63,133 lakh for H1 FY2027.
  • Income tax expenses (current and deferred) totaled ₹6,618 lakh in Q2 and ₹10,954 lakh in H1 FY2027.
  • Profit after tax and other comprehensive income totaled ₹19,571 lakh for Q2 and ₹32,305 lakh for H1 FY2027.

Regulatory and governance context

  • Unaudited financial statements prepared as per Indian Accounting Standard 34 (Ind AS 34)
  • Reports prepared in compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
  • Segment reporting consolidates health care and hygiene product lines into a single reportable segment.
  • Board meeting for approval held on November 12, 2026.

More News on Financial Results

View all

Latest corporate announcements and market updates in Financial Results.

View all news
Procter & Gamble Hygiene and Health Care Limited Reports | Stockk News